107 related articles for article (PubMed ID: 6239401)
21. [Immunopathology of lymphatic systemic diseases].
Huber H; Gattringer C
Wien Klin Wochenschr; 1983 May; 95(10):319-26. PubMed ID: 6351444
[TBL] [Abstract][Full Text] [Related]
22. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
[TBL] [Abstract][Full Text] [Related]
23. Sézary syndrome coexisting with B-cell chronic lymphocytic leukemia: case report and review of the literature.
Karsai S; Hou JS; Telang G; Kantor GR; Nowell PC; Vonderheid EC
Dermatology; 2008; 216(1):68-75. PubMed ID: 18032903
[TBL] [Abstract][Full Text] [Related]
24. Enumeration of T lymphocyte subsets by monoclonal antibodies in young and aged humans.
Nagel JE; Chrest FJ; Adler WH
J Immunol; 1981 Nov; 127(5):2086-8. PubMed ID: 6457861
[TBL] [Abstract][Full Text] [Related]
25. A monoclonal antibody detecting a 39,000 m.w. molecule that is present on B lymphocytes and chronic lymphocytic leukemia cells but is rare on acute lymphocytic leukemia blasts.
Zipf TF; Lauzon GJ; Longenecker BM
J Immunol; 1983 Dec; 131(6):3064-72. PubMed ID: 6358359
[TBL] [Abstract][Full Text] [Related]
26. Natural killer and antibody-dependent cytotoxic activities in T cell chronic lymphocytic leukemia.
Gupta S; Fernandes G
J Clin Lab Immunol; 1983 Nov; 12(3):155-7. PubMed ID: 6607357
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of human T cell subsets defined by monoclonal antibodies. V. Suppressor cells within the activated OKT4+ population belong to a distinct subset.
Thomas Y; Rogozinski L; Irigoyen OH; Shen HH; Talle MA; Goldstein G; Chess L
J Immunol; 1982 Mar; 128(3):1386-90. PubMed ID: 6460060
[TBL] [Abstract][Full Text] [Related]
28. Ultrastructural morphometry in the diagnosis of Sézary syndrome.
Payne CM; Glasser L
Arch Pathol Lab Med; 1990 Jul; 114(7):661-71. PubMed ID: 2194444
[TBL] [Abstract][Full Text] [Related]
29. [Membrane markers in chronic lymphoproliferative diseases].
Matutes E; San Miguel JF; Catovsky D
Med Clin (Barc); 1983 Mar; 80(7):334-50. PubMed ID: 6406774
[No Abstract] [Full Text] [Related]
30. Unusual lymphomas developing in chronic lymphocytic leukemia.
Raman SB; Saeed SM; Abraham JP
Henry Ford Hosp Med J; 1987; 35(4):251-5. PubMed ID: 3502342
[No Abstract] [Full Text] [Related]
31. HNK-1 monoclonal antibody (Leu-7) in the identification of abnormal expansions of large granular lymphocytes.
Pandolfi F; Semenzato G; de Rossi G; Quinti I; Guglielmi C; Pezzutto A; Lopez M; Tonietti G; Fontana L; Abo T; Aiuti F
Clin Exp Immunol; 1983 Jun; 52(3):641-7. PubMed ID: 6603302
[TBL] [Abstract][Full Text] [Related]
32. Acute lymphoblastic leukemia with Burkitt's lymphoma cells: membrane markers and serum immunoglobulin.
Preud'homme JL; Brouet JC; Danon F; Flandrin G; Schaison G
J Natl Cancer Inst; 1981 Feb; 66(2):261-4. PubMed ID: 6779044
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
[TBL] [Abstract][Full Text] [Related]
34. [Suppressor activity of OKT4+17+ cells from patients with adult T-cell leukemia].
Funato T; Hayashi M; Hirasawa Y; Ohtani H; Saito M; Kuto F; Tokuhiro H
Rinsho Ketsueki; 1984 Nov; 25(11):1754-9. PubMed ID: 6241944
[No Abstract] [Full Text] [Related]
35. T-lymphocytes with both helper- and suppressor markers on the same cell in chronic lymphocytic leukaemia.
Stavem P; Førre O; Brandtzaeg P; Nyberg H
Scand J Haematol; 1983 Feb; 30(2):177-82. PubMed ID: 6220464
[TBL] [Abstract][Full Text] [Related]
36. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
37. Abnormalities of immunoregulatory cells in immunodeficiency disease and cancer.
Broder S; Muul L; Megson M; Waldmann TA
Prog Clin Biol Res; 1981; 58():93-120. PubMed ID: 6455670
[No Abstract] [Full Text] [Related]
38. Antigenic characterization of a T-CLL with heteroantisera and monoclonal antibodies: evidence for the T cell lineage of an Ia-positive, Fc-IgG--positive, suppressor-cell subpopulation.
Strong DM; Pandolfi F; Slease RB; Budd JE; Woody JN
J Immunol; 1981 Jun; 126(6):2205-8. PubMed ID: 6453158
[TBL] [Abstract][Full Text] [Related]
39. Anti-ATLA (antibody to adult T-cell leukemia virus-associated antigen), highly positive in OKT4-positive mature T-cell malignancies.
Tobinai K; Nagai M; Setoya T; Shibata T; Minato K; Shimoyama M
Jpn J Clin Oncol; 1983; 13 Suppl 2():237-44. PubMed ID: 6603532
[TBL] [Abstract][Full Text] [Related]
40. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
